MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock from...
$7,988K
Proceeds from the
exercise of stock options
$100K
Net cash provided by
financing activities
$8,027K
Effect of foreign
currency on cash and cash...
$5K
Canceled cashflow
$61K
Net (decrease)
increase in cash and cash...
-$3,613K
Canceled cashflow
$8,032K
Change in fair value of
warrant liabilities
$984K
Stock-based compensation
$868K
Amortization of right-of-use
assets, operating...
$243K
Amortization of debt discount
$68K
Depreciation
$46K
Payment of offering
costs for the issuance...
$61K
Net cash used in
operating activities
-$11,645K
Canceled cashflow
$2,209K
Net loss
-$11,823K
Accrued expenses
-$602K
Prepaid expenses and
other current assets
$504K
Accounts payable
-$460K
Operating lease
liabilities
-$240K
Other long-term
prepaid assets
$225K
Back
Back
Cash Flow
Elicio Therapeutics, Inc. (ELTX)
Elicio Therapeutics, Inc. (ELTX)
source: myfinsight.com